Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome.
about
ALK Signaling and Target Therapy in Anaplastic Large Cell LymphomaPrimary systemic anaplastic large cell lymphoma in Korean adults: 11 years' experience at Asan Medical CenterBendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter studyPeripheral T-cell lymphoma: review and updates of current management strategiesALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.Preclinical results of camptothecin-polymer conjugate (IT-101) in multiple human lymphoma xenograft models.Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patientsEfficacy of peripheral blood stem cell transplantation versus conventional chemotherapy on anaplastic large-cell lymphoma:a retrospective study of 64 patients from a single center.Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome.Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941.A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.Association of Systemic Anaplastic Large Cell Lymphoma and Active Toxoplasmosis in a Child.Anaplastic large cell lymphoma with primary involvement of the skeletal muscle: A case reportPericardial involvement as an initial presentation of anaplastic large cell lymphoma.Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review
P2860
Q21129306-6954BE06-993C-462A-B0EA-0DEDF5FB87B2Q24652793-A2229A6A-068C-4BE9-9FAE-DDB66EF07C5CQ33434137-7D326621-6063-476E-AE0D-6C543306FB2CQ34479082-EEC37B9A-479A-438C-A5DA-401BB285A5ACQ35396628-BBFA03A5-086E-4012-85B6-4311D1EED59BQ35631349-E6FA75C0-3E8B-4B66-A535-3B3822E36E5DQ36162589-4350BAF6-0B9E-4EFF-9A83-91E55D58DF92Q37183767-69A55212-7535-424C-88A6-3E4979EF5F90Q37313150-FB172B92-81F1-463B-9A71-FC1EEECA7326Q37403652-62748E48-AD4C-4AF6-AC1C-04AB6FDCAF87Q37956318-3F719C43-8B33-4D38-A074-7F07C5C6419DQ40946717-37316C0E-6E9F-4868-9354-5382FAED1F18Q42419783-73ADBB17-8AD8-4DB0-80C3-A529E8FE8D5CQ42734453-210FB698-39E5-48C2-A3DE-B64DBA0012B8Q58799247-A5265D05-27B4-4B75-BE59-F07266B5BF76
P2860
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Primary anaplastic large-cell ...... immunophenotype, and outcome.
@en
type
label
Primary anaplastic large-cell ...... immunophenotype, and outcome.
@en
prefLabel
Primary anaplastic large-cell ...... immunophenotype, and outcome.
@en
P2093
P1433
P1476
Primary anaplastic large-cell ...... , immunophenotype, and outcome
@en
P2093
Dumontet C
Lederlin P
Petrella T
Plantier I
P304
P407
P577
1997-11-01T00:00:00Z